Vitamin D in HIV-Infected patients

Abstract

Observational studies have noted very high rates of low 25(OH)D (vitamin D) levels in both the general andHIV-infected populations. In HIV-infected patients, low 25(OH)D levels are likely a combination of both traditionalrisk factors and HIV-specific and antiretroviral therapy-specific contributors. Because of this unique risk profile,HIV-infected persons may be at greater risk for low 25(OH)D levels and frank deficiency and/or may respond to standardrepletion regimens differently than HIV-uninfected patients.Currently, the optimal repletion and maintenance dosingregimens for HIV-infected patients remain unknown, as dopotential benefits of supplementation thatmay be unique to the HIV-infected population. This paper reviews data published onHIVinfection and vitamin D health in adults over the last year. © Springer Science+Business Media, LLC 2011.